| Financial Year |
March 31 2023 |
| Monetary Funds |
400,918,243.34 |
| Held-for-trading Financial Assets |
1,800,000.00 |
| Notes Receivable |
57,034,626.86 |
| Accounts Receivable |
3,781,293,724.63 |
| Advances to Suppliers |
633,596,907.91 |
| Other Receivables |
158,157,124.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
20,000,000.00 |
| Inventories |
3,319,334.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
987,751,588.13 |
| Total Current Assets |
6,078,248,323.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
609,354,226.24 |
| Investment Properties |
254,532,337.00 |
| Fixed Assetes |
732,288,116.94 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
69,150,377.61 |
| R&D expenses |
-- |
| Goodwill |
341,725,726.89 |
| Long-Term Deferred and Prepaid Expenses |
8,131,442.11 |
| Deferred Income Tax Assets |
166,915,400.20 |
| Other Non-Current Assets |
3,954,336.25 |
| Sub-Total of Non-Current Assets |
2,727,255,137.31 |
| Total Assets |
8,805,503,461.09 |
| Short-Term Loans |
615,246,194.60 |
| Trading Financial liabilities |
-- |
| Notes Payable |
500,918,567.94 |
| Accounts Payable |
1,626,155,715.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,457,100.74 |
| Taxes Payable |
100,238,358.31 |
| Interest Payable |
-- |
| Dividend Payable |
3,800,000.00 |
| Other payables |
61,740,653.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
36,305,268.84 |
| Other Current Liabilities |
154,320,505.56 |
| Sub-Total of Current Liabilities |
3,650,632,356.20 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
25,873,030.74 |
| Deferred Income Tax Liabilities |
17,302,796.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
203,649,838.62 |
| Total Liabilities |
3,854,282,194.82 |
| Paid-In Capital(Or Share Stock) |
1,743,337,128.00 |
| Capital Surplus |
1,367,253,863.85 |
| Surplus Reserve |
199,114,183.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,456,965,996.79 |
| Minority Stockholder's Interest |
106,078,065.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,845,143,201.24 |
| Owner's Equity（Stockholder's Equity） |
4,951,221,266.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,805,503,461.09 |
